Acute myocardial infarction in systemic lupus erythematosus (report of a case)

Authors

  • Alejandra Parhuana B. Universidad de San Martín de Porres, Lima, Perú
  • Janeth Villegas G. Hospital Nacional Dos de Mayo, Lima, Perú
  • Wendy Sotelo D. Hospital Nacional Dos de Mayo, Lima, Perú
  • Luis Diaz T. Universidad de San Martín de Porres, Lima, Perú
  • Jorge Galarreta O. Universidad de San Martín de Porres, Lima, Perú
  • Iván Belzusarri P. Hospital Nacional Dos de Mayo, Lima, Perú https://orcid.org/0000-0003-4465-5650

DOI:

https://doi.org/10.24265/horizmed.2004.V4n2.05

Keywords:

Coronary arterial disease, Systemic lupus erythematosus, Acute myocardial infarction, Antiphospholipid antibody syndrome

Abstract

Occlusive Coronary Artery Disease (CAD) is a known established cardiovascular manifestation among patients with Systemic Lupus Erythematosus (SLE); mainly in young women. Several pathological processes can be responsible for producing vascular disease to the myocardium and infarction, being the Antiphospholipid Antibody Syndrome (AAS) an important cause in premenopausal women with SLE.
The clinical case of a young woman with SLE of recent beginning that presented an Acute Myocardial Infarction (AMI) is reported.

Downloads

Download data is not yet available.

Downloads

Published

2022-08-18

How to Cite

1.
Parhuana B. A, Villegas G. J, Sotelo D. W, Diaz T. L, Galarreta O. J, Belzusarri P. I. Acute myocardial infarction in systemic lupus erythematosus (report of a case). Horiz Med [Internet]. 2022Aug.18 [cited 2025May2];4(2):46-57. Available from: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2028

Issue

Vol. 4 No. 2 (2004): July - December

Section

Original article

License

Copyright (c) 2022 Horizonte Médico (Lima)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).